Eleanor de Groot
About Eleanor de Groot
Eleanor de Groot Chief Technology Officer
Eleanor de Groot currently serves as the Chief Technology Officer (CTO) in her organization. With extensive experience in the biotechnology sector, she brings a wealth of knowledge and leadership to her role, driving technological advancements and operational efficiencies.
Eleanor de Groot's Education and Expertise
Eleanor de Groot holds a Ph.D. and Master of Science degree in chemical engineering from Stanford University. She also earned a Bachelor of Science degree in chemical engineering from the Massachusetts Institute of Technology (MIT) and a Master of Business Administration from Rice University. Her educational background underpins her expertise in chemical engineering and business administration, allowing her to excel in technological and operational leadership.
Eleanor de Groot's Background in Biotechnology
With over two decades of experience in leading global operations in biotechnology companies, Eleanor de Groot has built a formidable career in this sector. She has held various important roles that have shaped the direction and success of the organizations she has worked for.
Eleanor de Groot's Role at Alaunos Therapeutics
Prior to her current position, Eleanor de Groot served as the Executive Vice President of Operations at Alaunos Therapeutics. During her tenure, she oversaw the development of novel cell therapy programs and led clinical manufacturing, quality, and process development, contributing significantly to the company's advancements in cell therapy.
Eleanor de Groot at Helsinn Therapeutics
Eleanor de Groot has held multiple roles of increasing responsibility within CMC management at Helsinn Therapeutics. She directed preparations for drug product commercialization and engaged extensively in global regulatory activities and technology transfers, ensuring the successful global deployment of Helsinn's therapeutic products.